Health In Tech reports non-dispute termination of its CTO

Rhea-AI Filing Summary

Health In Tech, Inc. reported that its Chief Technology Officer, Imran Yousuf, was terminated from his position on November 25, 2025. The company states that the termination was without cause and was not the result of any disagreement regarding its operations, policies, or practices. This update focuses solely on the leadership change and does not describe any changes to the company’s strategy or business activities.

Insights

Corporate governance analyst

Health In Tech discloses CTO termination without reported disagreements.

Health In Tech, Inc. has terminated its Chief Technology Officer, Imran Yousuf, effective November 25, 2025. The company explicitly states that this action was taken without cause and that it did not stem from disagreements over operations, policies, or practices.

This type of disclosure under Item 5.02 highlights a change in senior management but does not, on its face, indicate an operational dispute or strategic shift. The absence of described disagreements limits what can be inferred about internal issues from this event alone.

Subsequent public communications or future filings may provide more detail on how technology leadership responsibilities are allocated following November 25, 2025, but no such information is included in the current disclosure.

false 0002019505 0002019505 2025-11-25 2025-11-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

November 25, 2025

Date of Report (Date of earliest event reported)

Health In Tech, Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-42449		87-3545722
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

701 S. Colorado Ave, Suite 1 Stuart, FL		34994
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (888) 373-0333

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share		HIT		The Nasdaq Stock Market LLC (Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 25, 2025, Imran Yousuf, the Chief Technology Officer of Health in Tech, Inc. (the “Company”), was terminated from his position as Chief Technology Officer, without cause. Mr. Yousuf’s termination was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 26, 2025

HEALTH IN TECH, INC.

By:	/s/ Tim Johnson
Name:	Tim Johnson
Title:	Chief Executive Officer

2

FAQ

What did Health In Tech, Inc. (HIT) announce in this 8-K filing?

Health In Tech, Inc. disclosed that its Chief Technology Officer, Imran Yousuf, was terminated from his position on November 25, 2025.

Was the termination of Health In Tech’s CTO for cause?

No. The company states that Imran Yousuf was terminated from his position as Chief Technology Officer without cause.

Did Imran Yousuf have any disagreements with Health In Tech, Inc.?

The company states that Mr. Yousuf’s termination was not the result of any disagreement on matters related to operations, policies, or practices.

What role did Imran Yousuf hold at Health In Tech before his termination?

Imran Yousuf served as the Chief Technology Officer of Health In Tech, Inc. prior to his termination on November 25, 2025.

Who signed the 8-K for Health In Tech, Inc. (HIT)?

The report was signed on behalf of Health In Tech, Inc. by Tim Johnson, its Chief Executive Officer.

Does the 8-K filing mention any changes to Health In Tech’s operations or strategy?

The disclosure focuses on the termination of the Chief Technology Officer and states there was no disagreement over operations, policies, or practices; it does not describe operational or strategic changes.